Top Madison, WI Biotech Startups (20)
Elephas is developing a technology platform to assess how live tumor cells respond to cancer therapies. We are harnessing the latest advances in cancer biology, multimodal microscopy, engineering, and artificial intelligence to revolutionize cancer treatment. Cancer is a leading cause of death worldwide, with the number of patients projected to triple by 2060. Despite advances in precision medicine and a...
Proteovista is a microarray technology and applications for basic research and drug discovery company
Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development.
EyeKor is a network of established reading centers and clinical trial experts.
Intuitive Biosciences provides tuberculosis and specific pathogen-free tests for non-human primate (NHP) research operations.
Platypus Technologies develops analytical and life sciences products based upon the application of nanotechnology and materials science.
OUR MISSION: Empower Discovery. Enable Innovation. Improve Life. For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and...
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion
Capio Biosciences focuses on delivering high-value oncology diagnostics that can help inform patient care decisions and improve outcomes.
CLG -Multi-species Stem Cell Characterization Services and Products & Custom Assay Development
We provide phenotypic compound screening services for first-in-class drug discovery and drug repositioning
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).
Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.
Cellara is an early-stage Madison, Wisconsin-based biotechnology company developing workflow solutions to address critical issues.
Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multispecific antibodies and their derivatives. Invenra's proprietary technologies combine our highly developable B-Body™ bispecific platform with high throughput functional screening, enabling the optimization of unprecedented numbers of bispecific antibodies in phenotypic assays. Invenra has a pipeline of immuno-oncology bispecific antibodies that are currently in preclinical...
